146 Conversations With Participants in the RECONNECT Studies About Their Experiences With Bremelanotide for Treatment of Hypoactive Sexual Desire Disorder. (1st April 2019) - Koochaki, P.; Revicki, D.; Wilson, H.; Pokrzywinsiki, R.; Jordan, R.; Lucas, J.; Williams, L.; Krop, J.